NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,136 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,136 Papers indexed
1,440 Papers AI scored
40,136 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-06 10:15 AM
1 [Impact of tumor necrosis factor superfamily member 4 gene polymorphisms on the risk of Crohn's disease and clinical efficacy of ustekinumab]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics — Nov 06, 2026 2 Primary cervical ganglioneuroblastoma: diagnostic challenges, management, and outcomes - a systematic review. Acta oto-laryngologica — Nov 06, 2026 3 Implementing childhood cancer survivorship care plans: qualitative perspectives and experiences from Australian primary care physicians. Family medicine and community health — Nov 06, 2026 4 Clinically significant portal hypertension rather than ALBI grade predicts prognosis in advanced hepatocellular carcinoma. Annals of hepatology — Nov 06, 2026 5 Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: long-term efficacy and endocrine analysis. Blood advances — Nov 06, 2026 6 Enucleation Versus Anatomical Resection of Malignant Pancreatic Tumors in Children and Young Adults. The Journal of surgical research — Nov 06, 2026 7 Heat-inactivated Bifidobacterium adolescentis LA20 alleviates doxorubicin-induced senescence and barrier dysfunction in feline intestinal epithelial cells. American journal of veterinary research — Nov 06, 2026 8 Don't Worry, We'll Call You: An Anticipatory Guidance Framework for Addressing Test-Related Anxiety-Scanxiety. Journal of participatory medicine — Nov 06, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40136 results
C
Case Report: Activated phosphoinositide 3-kinase δ syndrome mimicking Hyper-IgM syndrome: early hepatosplenomegaly as a key diagnostic clue.
PMID 42729315 Published: 2026-08-28 Ingested: 2026-09-15 09:15 AM Frontiers in immunology
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 48.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review.
PMID 42098995 Published: 2026-05-08 Ingested: 2026-08-02 12:07 AM The American journal of case reports
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 48.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling.
PMID 41938370 Published: 2026-03-24 Ingested: 2026-08-02 12:06 AM Journal of orthopaedic translation
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 43.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
CRISPR-Cas9 Genome-Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies.
PMID 41914542 Published: 2026-03-31 Ingested: 2026-08-02 12:06 AM Medicinal research reviews
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 23.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.

C
Registration of childhood cancer - current status and perspectives.
PMID 41553808 Published: 2025-01-01 Ingested: 2026-08-02 12:03 AM Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Case Report: Metronidazole-induced encephalopathy in a patient with acute myeloid leukemia type 2 and a literature review of the pediatric case reports.
PMID 41089185 Published: 2025-09-29 Ingested: 2026-08-02 12:03 AM Frontiers in pediatrics
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 48.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Upadacitinib for difficult-to-treat paediatric Crohn's disease.
PMID 40814571 Published: 2025-04-14 Ingested: 2026-08-02 12:04 AM JPGN reports
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Environmental Exposures Increase Health Risks in Childhood Cancer Survivors.
PMID 40647521 Published: 2025-07-02 Ingested: 2026-08-02 12:04 AM Cancers
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
NHEJ1 Splice Variants Associated With Bone Marrow Failure and Hematologic Malignancy.
PMID 40580024 Published: 2025-06-28 Ingested: 2026-08-02 12:04 AM Pediatric blood & cancer
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

C
Evaluation of PRDM10 gene rearrangement by immunohistochemistry and molecular methods in unclassifiable undifferentiated soft tissue tumors.
PMID 40560238 Published: 2025-06-25 Ingested: 2026-08-02 12:04 AM Medical molecular morphology
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Human Herpesvirus 8 in Solid Organ Transplant Donors and Recipients: Need for Screening? A Dutch Seroprevalence Pilot Study.
PMID 40558092 Published: 2025-07-01 Ingested: 2026-08-02 12:04 AM Journal of medical virology
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.0; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Cardiology follow-up in childhood cancer survivors-Recommendations versus compliance.
PMID 40524339 Published: 2025-06-16 Ingested: 2026-08-02 12:04 AM Journal of investigative medicine : the official publication of the American Federation for Clinical Research
AI -
Standard 56.6
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 56.6/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 28.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Previous
Page 2393 of 3345
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic